Vaccine for Parasitic Diseases
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (21 July 2023) | Viewed by 1791
Special Issue Editors
Interests: susceptibility and resistance in helminths of veterinary; anti-parasitic drugs; drug mechanisms of action and resistance; molecular and immunological diagnostic techniques; vaccine development
Interests: veterinary parasitology
Special Issue Information
Dear Colleagues,
Significant efforts and progress have been made over the last few years in the development of vaccines against parasitic diseases. However, an effective vaccine is not yet available. The difficulties in developing a vaccine against parasitic diseases are complicated not only by the necessity to identify (and produce) appropriate, protective antigens but also a lack of complete understanding of the types of immune responses needed for protection. Despite these hurdles, most scholars are trying to design and develop more advanced vaccines for parasitic diseases.
We are pleased to invite you to submit your new research on vaccines for parasitic diseases to this Special Issue. This Special Issue focuses on novel and repurposed antiparasitic drugs, drug mechanisms of action and resistance, molecular and immunological diagnostic techniques, vaccine development and parasite–host interactions.
We look forward to receiving your contributions.
Dr. Jeba Jesudoss Chelladurai
Dr. Matthew Thomas Brewer
Dr. Miriam Tendler
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
